Sign in →

JAK2, CALR, and MPL Mutation Analysis (MPN NGS)

eDH Procedure Code(s)

LAB2058 MPN Screening Panel
LAB4320 JAK2, CALR, and MPL Mutation Analysis

Test Information

Thrombocytosis, Leukocytosis or other/mixed; clinically concerning for myeloproliferative neoplasm; This Next Generation Sequencing based assay is intended to detect JAK2 p.V617F as well as other other non-V617F variants in JAK2 exons 12 to 15,CALR exon 9 variants, and MPL W515 variants.

Order Questions

LAB2058 MPN Screening Panel
  • Indication for Study:
LAB4320 JAK2, CALR, and MPL Mutation Analysis
  • Indication for Study:

Specimen Information

Specimen Type Specimen Source Acceptable Containers Minimum Test Volume (mL)
Blood Blood, Venous Lav4-R 1.0
Blood Blood, Venous Lav6-R 1.0

Shipping and Handling

Processing Instructions: N/A

Transport Temperature: Refrigerated at 4°C
Transport Instructions: N/A

Specimen Stability Unprocessed
Unprocessed: Refrigerated at 4°C for 7 days
Specimen Stability Post Processing
Ambient: N/A
Refrigerate: N/A
Frozen: N/A

Test Components

Component LOINC Code
NGS REPORT STATUS 62364-5

Turnaround Time (TAT)

15 Days

CPT Code(s)

81279
81219
81339

Performing Lab Section

Molecular Pathology

Performing Lab(s)

Dartmouth Hitchcock Medical Center Laboratory (MHMH)